Neuroinflammatory phenotypes and their roles in Alzheimer's disease

Neurodegenerative Diseases

Volumn 13, Issue 2-3, 2014, Pages 183-185

  Wilcock, Donna M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Glia; Inflammation; Macrophage; Microglia

Indexed keywords

ARGINASE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 2;

ALZHEIMER DISEASE; ARTICLE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; MACROPHAGE; NERVOUS SYSTEM INFLAMMATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WOUND HEALING; AGED; CEREBELLUM; COMORBIDITY; CONFERENCE PAPER; DISEASE COURSE; NEUROPATHOLOGY; PROTEIN SUBUNIT; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALZHEIMER DISEASE; BRAIN; CLUSTER ANALYSIS; FEMALE; HUMANS; INFLAMMATION; MALE; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 84896846872     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000354228     Document Type: Article

References (13)

1. Perlmutter LS, Barron E, Chui HC: Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease. Neurosci Lett 1990; 119: 32-36.
2. Combs CK, Johnson DE, Cannady SB, Lehman TM, Landreth GE: Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. J Neurosci 1999; 19: 928-939.
3. McGeer EG, McGeer PL: The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol 1998; 33: 371-378.
4. Mosser DM, Edwards JP: Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969.
5. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, et al: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-686.
6. Mosser DM: The many faces of macrophage activation. J Leukoc Biol 2003; 73: 209-212.
7. Martinez FO, Helming L, Gordon S: Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009; 27: 451-483.
8. Edwards JP, Zhang X, Frauwirth KA, Mosser DM: Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol 2006; 80: 1298-1307.
9. Schmitt FA, Wetherby MM, Wekstein DR, Dearth CM, Markesbery WR: Brain donation in normal aging: procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project. Gerontologist 2001; 41: 716-722.
10. Nelson PT, Jicha GA, Schmitt FA, Liu H, Davis DG, et al: Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles 'do count' when staging disease severity. J Neuropathol Exp Neurol 2007; 66: 1136-1146.
11. Schmitt FA, Nelson PT, Abner E, Scheff S, Jicha GA, et al: University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures, and neuropathology. Curr Alzheimer Res 2012; 9: 724-733.
12. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.
13. Das P, Howard V, Loosbrock N, Dickson D, Murphy MP, et al: Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/-knock-out mice. J Neurosci 2003; 23: 8532-8538.